Elaboration of a Multi-dimensional Indicator of Quality in Palliative Care

The purpose of this study is to elaborate a multi-dimensional indicator of the quality in palliative care for patients of end-of-life.

The study will, as secondary objectives:

* elaborate in a standard manner one set of indicators of organization and inner working of a palliative care setting. * compare according to these indicators, the qualities of 3 types of palliative care: palliative care unit in hospitals, specified identified bed for palliative care patients and non-specified bed. * explore the relationship between organizational aspects and results in term of burden.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Terminal Illness Death End of Life Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Maison Médicale Jeanne Garnier

Paris, Île-de-France Region, 75015, France

About this study

A multicentric study aims on quality of palliative care and will be conducted in three types of 7 palliative care settings: two hospices, two hospital-based palliative care units and three medical units where a mobile palliative care team intervenes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Aged ≥ 18 years.
Patient with serious progressive illness and in terminal phase (life expectancy < 3 months): OMS stage is 3 or 4, regardless of etiology.
Patient informed their diagnosis or not.
Hospitalized at the moment of inclusion in one of the following care settings: palliative care unit, identified bed or non-identified bed in a care department of short stay.
No-oppose to participate to the study, by patients, their families or trusted person.

Exclusion criteria

Patient has difficulties in reading, writing or understanding french language, also their family.
Hospitalization in the palliative care setting < 48 hours.

Treatment and study plan

Primary outcomes

Questionnaire for patients

Time frame: From date of enrollment until the date of first documented leaving from hospital or date of death, whichever came first, up to 2 years

A questionnaire has been elaborated beforehand by the study will be answered by patients in order to evaluate quality such as reliability, dimensionality and validity against criterion.
Indicator for medical files

Time frame: At enrollment

The indicators have been defined by the study, in order to evaluate quality of medical files, such as completeness and discriminatory capacity.
Indicator for caregivers

Time frame: From date of enrollment until the date of receiving questionnaire returned by caregiver, up to 2 years
In order to evaluate quality such as reliability and dimensionality, a questionnaire will be answered by caregivers:
- the Nursing Stress Scale (NSS).
Questionnaire for families

Time frame: From date of enrollment until the date of receiving questionnaire sent by family, up to 2 years

A questionnaire has been elaborated, will be answered by patients' families.

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Registry information

Acronym: QUALI-PALLI

Important dates

Study start: 2012
Primary completion: 2014
Study completion: 2014
First posted: Jun 28, 2016
Registry last updated: Jun 28, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed